Tag Archives: Mark H. Stoler MD

Roche’s cobas HPV Test for first-line primary screening test for cervical cancer gets FDA approval

Expanded indication makes cobas HPV Test the only test approved in U.S. that can be used instead of Pap in first-line primary screening in women 25 and older Basel, 29-4-2014 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that … Read the full press release